Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
NSE and BSE top losers on 10 Aug 2026: PFC, Bharat Forge, NLC India, REC and Ashapura Minechem fell on sector-led selling, results-linked moves and technical breakdowns.
Hitachi Energy, Paytm and Titan led India’s top gainers on 10 Aug 2026. Here is what moved large, mid and small caps, and the key triggers.
Exicom Tele-Systems has scheduled its Q1 FY27 board meeting and investor call on August 10, 2026, as investors track recent losses, revenue movement, and trading-window timelines.
Wockhardt will consider and approve Q1 FY27 unaudited results on August 10, 2026, with the trading window shut until 48 hours after disclosure.
Wockhardt’s board meets on Aug 10, 2026 to approve Q1 FY27 results, after FY26 turned profitable with higher EBITDA and Q4 PAT of Rs 164 crore.
Sharp Investments has issued an AGM corrigendum and set book closure dates ahead of a shareholder vote on a preferential allotment tied to acquiring Rajal Lefin & Commercial.
BASML’s H1 FY26 unaudited results show stable revenue around ₹445 crore, a sharp swing in continuing operations PBT, stronger cash flow, and lower debt after a rights issue.
Sharp Investments issued a corrigendum ahead of its 49th AGM on August 7, 2026, as shareholders vote on a share-swap acquisition of Rajal Lefin & Commercial.
Jupiter Industries & Leasing will meet on August 10, 2026 to approve unaudited June-quarter results and a limited review report, with the trading window shut from July 1.
Monarch Networth Capital will hold a board meeting on August 10, 2026 to approve Q1 FY27 unaudited results, with the trading window shut till August 12, 2026.
UVS Hospitality and Services will hold a board meeting on 13 August 2026 to approve Q1 FY27 unaudited results, with the trading window shut until 48 hours after disclosure.
JTL Industries posted record Q1FY27 revenue and PAT, WPIL reported sharp profit growth, while Jupiter Industries scheduled board meetings and disclosed FY26 losses and compliance updates.
Windlas Biotech has scheduled its Q1 FY27 earnings conference call for August 11, 2026, as investors track estimates, shareholding trends, and recent FY26 performance metrics.
Windlas Biotech reported Q4 FY26 net sales of ₹238.50 crore with net profit of ₹15.99 crore, declared a ₹6.30 dividend, and scheduled an August 11, 2026 call.
Stock market today: Nifty slipped to 24,570 and Sensex fell 456 points as investors tracked oil stability, US inflation cues and selective company-specific developments.
India’s IPO calendar is packed this week as nine mainboard and SME issues open between August 10 and 14, targeting a combined fundraise of about ₹7,681 crore.